Complement takes its Toll: an inflammatory crosstalk between Toll-like receptors and the receptors for the complement anaphylatoxin C5aHOLST, B; RABY, A.-C; HALL, J. E et al.Anaesthesia. 2012, Vol 67, Num 1, pp 60-64, issn 0003-2409, 5 p.Article

The role of the complement anaphylatoxins in the recruitment of eosinophilsDISCIPIO, Richard G; SCHRAUFSTATTER, Ingrid U.International immunopharmacology. 2007, Vol 7, Num 14, pp 1909-1923, issn 1567-5769, 15 p.Article

Increased anaphylatoxins (C3a and C4a) in psoriatic seraOHKOHCHI, K; TAKEMATSU, H; TAGAMI, H et al.British journal of dermatology (1951). 1985, Vol 113, Num 2, pp 189-196, issn 0007-0963Article

CHARACTERIZATION OF HUMAN C4A ANAPHYLATOXINGORSKI JP; HUGLI TE; MULLER EBERHARD HJ et al.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 6; PP. 2707-2711; BIBL. 37 REF.Article

Biocompatibility of hemodialysis membranes: evaluation with C_3a anaphylatoxin radioimmunoassaysCHENOWETH, D. E.ASAIO journal. 1984, Vol 7, Num 2, pp 44-49, issn 0162-1432Article

Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancerLANGONE, J. J; DAS, C; BENNETT, D et al.The Journal of immunology (1950). 1984, Vol 133, Num 2, pp 1057-1063, issn 0022-1767Article

Novel function of C4a anaphylatoxin : release from monocytes of protein which inhibits monocyte chemotaxisTSURUTA, T; YAMAMOTO, T; MATSUBARA, S et al.The American journal of pathology. 1993, Vol 142, Num 6, pp 1848-1857, issn 0002-9440Article

THE ACTIVE SITE OF C3A ANAPHYLATOXINCAPORALE LH; TIPPETT PS; ERICKSON BW et al.1980; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1980; VOL. 255; NO 22; PP. 10758-10763; BIBL. 28 REF.Article

Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsisHACK, C. E; NUIJENS, J. H; FELT-BERSMA, R. J. F et al.The American journal of medicine. 1989, Vol 86, Num 1, pp 20-26, issn 0002-9343Article

Characterization of the regulation of complement-derived chemotactic factors in blunt traumaMADERAZO, E. G; MOORE, M; WORONICK, C. L et al.The Journal of infectious diseases. 1988, Vol 157, Num 2, pp 364-367, issn 0022-1899Article

Development of a simple radioimmunoassay for human C3aLAMCHE, H. R; PAUL, E; SCHLAG, G et al.Inflammation. 1988, Vol 12, Num 3, pp 265-276, issn 0360-3997Article

Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residuesUNSON, C. G; ERICKSON, B. W; HUGLI, T. E et al.Biochemistry (Easton). 1984, Vol 23, Num 4, pp 585-589, issn 0006-2960Article

Anaphylatoxins inhibit C2 productionLAPPIN, D; DAMERAU, B; WHALEY, K et al.Clinical and experimental immunology (Print). 1983, Vol 54, Num 2, pp 455-460, issn 0009-9104Article

Effect of psoralen + ultraviolet-a on the chemotactic activity of polymorphonuclear neutrophils towards anaphylatoxin C5a des ArgESAKI, K; MIZUNO, N.Photochemistry and photobiology. 1992, Vol 55, Num 5, pp 783-788, issn 0031-8655Article

Anaphylatoxin C3a enhances mucous glycoprotein release from human airways in vitroMAROM, Z; SHELHAMER, J; BERGER, M et al.The Journal of experimental medicine. 1985, Vol 161, Num 4, pp 657-668, issn 0022-1007Article

Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vesselsMARCEAU, F; HUGLI, T. E.The Journal of pharmacology and experimental therapeutics. 1984, Vol 230, Num 3, pp 749-754, issn 0022-3565Article

Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase NCAMPBELL, William D; LAZOURA, Eliada; OKADA, Noriko et al.Microbiology and immunology. 2002, Vol 46, Num 2, pp 131-134, issn 0385-5600Article

Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generationTAMIYA, T; MAEO, Y; OKADA, T et al.Journal of thoracic and cardiovascular surgery. 1992, Vol 103, Num 1, pp 78-86, issn 0022-5223Article

The possibility of improving biocompatibility by removing anaphylatoxins from the circuit of blood-perfused artificial organsOKA, T.ASAIO transactions. 1989, Vol 35, Num 4, pp 778-783, issn 0889-7190, 6 p.Article

Generation and removal of anaphylatoxins during hemofiltration with five different membranesJORSTAD, S; SMEBY, L. C; BALSTAD, T et al.Blood purification. 1988, Vol 6, Num 6, pp 325-335, issn 0253-5068Article

Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN)HUEY, R; HUGLI, T. E.The Journal of immunology (1950). 1985, Vol 135, Num 3, pp 2063-2068, issn 0022-1767Article

IMMUNOLOGICAL ACTIVE PEPTIDES1981; MOL. CELL. BIOCHEM.; ISSN 0300-8177; NLD; DA. 1981; VOL. 41; 136 P.; BIBL. DISSEM.Serial Issue

CHEMOTACTIC RESPONSE TO HUMAN C3A AND C5A ANAPHYLATOXINS. I. EVALUATION OF C3A AND C5A LEUKOTAXIS IN VITRO AND UNDER SIMULATED IN VIVO CONDITIONS.FERNANDEZ HN; HENSON PM; OTANI A et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 1; PP. 109-115; BIBL. 40 REF.Article

RELATION BETWEEN STIMULUS INTENSITY AND NEUTROPHIL CHEMOTACTIC RESPONSE.KELLER HU; WISSLER JH; HESS MW et al.1977; EXPERIENTIA; SUISSE; DA. 1977; VOL. 33; NO 4; PP. 534-536; BIBL. 15 REF.Article

Structural elucidation of the 8-methoxypsoralen oxidized product that inhibits the chemotactic activity of polymorphonuclear neutrophils toward anaphylatoxin C5aMIZUNO, N; ESAKI, K; SAKAKIBARA, J et al.Photochemistry and photobiology. 1991, Vol 54, Num 5, pp 697-701, issn 0031-8655Article